BERLIN — Swiss drug maker Novartis AG has agreed with its outgoing chairman to scrap plans for a farewell noncompete deal that could have netted him up to $78 million.
The announcement followed criticism from some of the company’s shareholders and politicians.
Comments
As soon as I'm done being horrified with his current pay scale and platinum parachute, I'll be able to process the happier news that he's OK with the fact that he isn't going to get it because he really didn't need it anyway. Cut, print...... WOW!